{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:23:09Z","timestamp":1782854589724,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1124\/dmd.32.2.235","type":"journal-article","created":{"date-parts":[[2004,1,26]],"date-time":"2004-01-26T20:25:10Z","timestamp":1075148710000},"page":"235-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL"],"prefix":"10.1016","volume":"32","author":[{"given":"Akiko","family":"Ohno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobumitsu","family":"Hanioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Jinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.32.2.235_bib1","series-title":"Interindividual Variability in Human Drug Metabolism","first-page":"358","article-title":"Interindividual variation of UDP-glucuronosyltransferase and drug glucuronidation","author":"Burchell","year":"2001"},{"key":"10.1124\/dmd.32.2.235_bib2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/dmd.32.2.235_bib3","first-page":"73","article-title":"The glucuronidation of opioids, other xenobiotics and androgens by human UGT2B7Y(268) and UGT2B7H(268).","volume":"26","author":"Coffman","year":"1998","journal-title":"Drug Metab Dispos"},{"issue":"Suppl 11","key":"10.1124\/dmd.32.2.235_bib4","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/00005344-198710111-00018","article-title":"Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.","volume":"10","author":"Eggertson","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.32.2.235_bib5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJM199812103392407","article-title":"Carvedilol.","volume":"339","author":"Frishman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.32.2.235_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3109\/00498259009046823","article-title":"Identification of two major biliary metabolites of rats.","volume":"20","author":"Fujimaki","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.32.2.235_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002280050256","article-title":"Carvedilol versus verapamil in chronic stable angina: a multicenter trial.","volume":"52","author":"Hauf-Zachariou","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.32.2.235_bib8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.","volume":"101","author":"Iyer","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.32.2.235_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-3565(24)39177-3","article-title":"CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences.","volume":"294","author":"Johnson","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.32.2.235_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","article-title":"UDP-glucuronosyltransferases.","volume":"1","author":"King","year":"2000","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.32.2.235_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3748\/wjg.v7.i6.841","article-title":"Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells.","volume":"7","author":"Li","year":"2001","journal-title":"World J Gastroenterol"},{"key":"10.1124\/dmd.32.2.235_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.32.2.235_bib13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1023\/A:1018989211864","article-title":"Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.","volume":"16","author":"Madani","year":"1999","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.32.2.235_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1388-9842(99)00071-9","article-title":"Combination therapy with carvedilol and amiodarone in patients with severe heart failure.","volume":"2","author":"N\u00e4gele","year":"2000","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 1","key":"10.1124\/dmd.32.2.235_bib15","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/00005344-199219001-00022","article-title":"A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.","volume":"19","author":"Nahrendorf","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.32.2.235_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/jpet.102.036533","article-title":"Stereoselective metabolism of bufuralol racemate and enantiomers in human liver microsomes.","volume":"303","author":"Narimatsu","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 11","key":"10.1124\/dmd.32.2.235_bib17","first-page":"S114","article-title":"Pharmacokinetics and disposition of carvedilol in humans.","volume":"10","author":"Neugebauer","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.32.2.235_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03189969","article-title":"Metabolism of carvedilol in man.","volume":"16","author":"Neugebauer","year":"1991","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.32.2.235_bib19","first-page":"970","article-title":"In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol.","volume":"25","author":"Oldham","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.2.235_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.32.2.235_bib21","doi-asserted-by":"crossref","first-page":"25636","DOI":"10.1016\/S0021-9258(19)74437-8","article-title":"Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4.","volume":"268","author":"Pillot","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.32.2.235_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","article-title":"Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.","volume":"129","author":"Ritter","year":"2000","journal-title":"Chem-Biol Interact"},{"key":"10.1124\/dmd.32.2.235_bib23","first-page":"958","article-title":"Metabolism of carvedilol in dogs, rats and mice.","volume":"26","author":"Schaefer","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.2.235_bib24","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","article-title":"Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.","volume":"275","author":"Strassburg","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.32.2.235_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/mol.52.2.212","article-title":"Differential expression of the UGT1A locus in human liver, biliary and gastric tissue.","volume":"52","author":"Strassburg","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.32.2.235_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression and disease.","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.32.2.235_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0009-9236(95)90036-5","article-title":"Stereoselective disposition of carvedilol is determined by CYP2D6.","volume":"57","author":"Zhou","year":"1995","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.32.2.235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:55:36Z","timestamp":1739897736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624028587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0090955624028587"],"URL":"https:\/\/doi.org\/10.1124\/dmd.32.2.235","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.32.2.235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}